Bristol-Myers Squibb Rights (BMY.R)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▼ | Share change | % change to portfolio | |
| Q1 2021 | |||||
| ≡ | David Abrams - Abrams Capital Management | Sell 100.00% | 24,800,355 | 0.48 | |
| ≡ | Daniel Loeb - Third Point | Sell 100.00% | 6,000,000 | 0.03 | |
| ≡ | Viking Global Investors | Sell 100.00% | 8,825,899 | 0.02 | |
| Q4 2020 | |||||
| ≡ | Viking Global Investors | Reduce 52.04% | 9,575,370 | 0.02 | |
| ≡ | David Rolfe - Wedgewood Partners | Sell 100.00% | 131,557 | 0.05 | |
| Q3 2020 | |||||
| ≡ | David Rolfe - Wedgewood Partners | Reduce 2.35% | 3,172 | 0.00 | |
| ≡ | Viking Global Investors | Reduce 2.99% | 566,750 | 0.00 | |
| ≡ | David Abrams - Abrams Capital Management | Reduce 36.21% | 8,402,514 | 0.60 | |
| Q2 2020 | |||||
| ≡ | Viking Global Investors | Reduce 3.42% | 671,182 | 0.01 | |
| ≡ | David Rolfe - Wedgewood Partners | Reduce 9.52% | 14,172 | 0.01 | |
| ≡ | Daniel Loeb - Third Point | Reduce 14.29% | 1,000,000 | 0.05 | |
| Q1 2020 | |||||
| ≡ | Viking Global Investors | Reduce 24.48% | 6,364,383 | 0.13 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.